Skip to main content

Protagonist Therapeutics, Inc 10-Q for FY2024 Q2

Protagonist Therapeutics, Inc (PTGX)

10-Q 2024-08-06 For: 2024-06-30
View Original
Added on April 07, 2026

About this 10-Q

Protagonist Therapeutics, Inc filed this 10-Q on August 6, 2024, covering the quarter ended June 30, 2024 (FY2024 Q2).

Headline figures

Quarter ended June 30, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$4.17M
Net loss
$30.62M
compared with a net loss of $38.46M a year earlier
Diluted EPS
-$0.50
compared with -$0.68 a year earlier